Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Thall

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Bone Marrow Transplantation|June 27, 2012
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALLP Kebriaei, T Madden, X Wang, et al.
Leukemia|February 28, 2015
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myelomaN Shah, P F Thall, P S Fox, et al.
Leukemia|September 23, 2016
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignanciesM H Qazilbash, E Wieder, P F Thall, et al.
Blood|February 7, 2001
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationS Giralt, P F Thall, I Khouri, et al.
Leukemia|November 9, 2007
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndromeM de Lima, R E Champlin, P F Thall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancerJ A Ajani, L Xiao, J A Roth, et al.
Cancer|December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neckJ E Tseng, B S Glisson, F R Khuri, et al.
Bone Marrow Transplantation|December 20, 2016
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patientsB S Andersson, P F Thall, B C Valdez, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Bone Marrow Transplantation|June 27, 2012
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALLP Kebriaei, T Madden, X Wang, et al.
Leukemia|February 28, 2015
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myelomaN Shah, P F Thall, P S Fox, et al.
Leukemia|September 23, 2016
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignanciesM H Qazilbash, E Wieder, P F Thall, et al.
Blood|February 7, 2001
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationS Giralt, P F Thall, I Khouri, et al.
Leukemia|November 9, 2007
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndromeM de Lima, R E Champlin, P F Thall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2013
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancerJ A Ajani, L Xiao, J A Roth, et al.
Cancer|December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neckJ E Tseng, B S Glisson, F R Khuri, et al.
Bone Marrow Transplantation|December 20, 2016
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patientsB S Andersson, P F Thall, B C Valdez, et al.
Pageof 6